Galacto-N-biose is neuroprotective against glutamate-induced excitotoxicity in vitro.
暂无分享,去创建一个
Y. Shinoda | M. Kitaoka | M. Nakajima | T. Furuichi | Tsutomu Takahashi | Y. Fujiwara | Yui Nakajima | S. Tatsumi | Hirotoshi Iguchi
[1] Jinghuan Li,et al. Targeting blood-brain-barrier transcytosis – perspectives for drug delivery , 2017, Neuropharmacology.
[2] A. Traweger,et al. Pharmaceutical Targeting of the Brain. , 2016, Current pharmaceutical design.
[3] Lauren E. Salminen,et al. Oxidative stress and genetic markers of suboptimal antioxidant defense in the aging brain: a theoretical review , 2014, Reviews in the neurosciences.
[4] Y. Shinoda,et al. BDNF enhances spontaneous and activity-dependent neurotransmitter release at excitatory terminals but not at inhibitory terminals in hippocampal neurons , 2014, Front. Synaptic Neurosci..
[5] L. Schneider,et al. Lack of evidence for the efficacy of memantine in mild Alzheimer disease. , 2011, Archives of neurology.
[6] A. Moran,et al. Sweet-talk: role of host glycosylation in bacterial pathogenesis of the gastrointestinal tract , 2011, Gut.
[7] H. Hirase,et al. Calcium-dependent activator protein for secretion 2 (CAPS2) promotes BDNF secretion and is critical for the development of GABAergic interneuron network , 2010, Proceedings of the National Academy of Sciences.
[8] Y. Shinoda,et al. Persistent Synapse Loss Induced by Repetitive LTD in Developing Rat Hippocampal Neurons , 2010, PloS one.
[9] A. Lau,et al. Glutamate receptors, neurotoxicity and neurodegeneration , 2010, Pflügers Archiv - European Journal of Physiology.
[10] Z. Qin,et al. Molecular and cellular mechanisms of excitotoxic neuronal death , 2010, Apoptosis.
[11] M. Tymianski,et al. Calcium, ischemia and excitotoxicity. , 2010, Cell calcium.
[12] M. Nishimoto,et al. One-pot enzymatic production of beta-D-galactopyranosyl-(1-->3)-2-acetamido-2-deoxy-D-galactose (galacto-N-biose) from sucrose and 2-acetamido-2-deoxy-D-galactose (N-acetylgalactosamine). , 2009, Carbohydrate research.
[13] J. Sepulcre,et al. Memantine induces reversible neurologic impairment in patients with MS , 2009, Neurology.
[14] Z. Qin,et al. Molecular mechanisms of excitotoxicity and their relevance to pathogenesis of neurodegenerative diseases , 2009, Acta Pharmacologica Sinica.
[15] Peng Huang,et al. Redox regulation of cell survival. , 2008, Antioxidants & redox signaling.
[16] L. Massieu,et al. Excitotoxic neuronal death and the pathogenesis of Huntington's disease. , 2008, Archives of Medical Research.
[17] M. Nishimoto,et al. Identification of N-Acetylhexosamine 1-Kinase in the Complete Lacto-N-Biose I/Galacto-N-Biose Metabolic Pathway in Bifidobacterium longum , 2007, Applied and Environmental Microbiology.
[18] W. Robberecht,et al. The role of excitotoxicity in the pathogenesis of amyotrophic lateral sclerosis. , 2006, Biochimica et biophysica acta.
[19] Claire Mount,et al. Alzheimer disease: progress or profit? , 2006, Nature Medicine.
[20] D. Hovda,et al. Evidence for Energy Failure following Irreversible Traumatic Brain Injury , 1999, Annals of the New York Academy of Sciences.
[21] M. Moskowitz,et al. Pathobiology of ischaemic stroke: an integrated view , 1999, Trends in Neurosciences.
[22] G. Albers,et al. Dose escalation study of the NMDA glycine-site antagonist licostinel in acute ischemic stroke. , 1999, Stroke.
[23] K. Savolainen,et al. Glutamate-stimulated ROS production in neuronal cultures: interactions with lead and the cholinergic system. , 1998, Neurotoxicology.
[24] J. Taylor‐Papadimitriou,et al. Comparison of O-Linked Carbohydrate Chains in MUC-1 Mucin from Normal Breast Epithelial Cell Lines and Breast Carcinoma Cell Lines: , 1996, The Journal of Biological Chemistry.
[25] Richard H. P. Porter,et al. Glutamate and Parkinson’s disease , 1996, Molecular Neurobiology.
[26] J. Grotta,et al. Safety and tolerability of the glutamate antagonist CGS 19755 (Selfotel) in patients with acute ischemic stroke. Results of a phase IIa randomized trial. , 1995, Stroke.
[27] K. Lees,et al. Clinical experience with excitatory amino acid antagonist drugs. , 1995, Stroke.
[28] W. Löscher,et al. The behavioural effects of MK-801 in rats: involvement of dopaminergic, serotonergic and noradrenergic systems. , 1992, European journal of pharmacology.
[29] D. Choi,et al. Calcium and excitotoxic neuronal injury , 1991, Journal of the Neurological Sciences.
[30] L. Facci,et al. Hypoglycemic neurotoxicity in vitro: Involvement of excitatory amino acid receptors and attenuation by monosialoganglioside GM1 , 1990, Neuroscience.
[31] S. Rothman,et al. Glutamate neurotoxicity in vitro: antagonist pharmacology and intracellular calcium concentrations , 1990, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[32] R. C. Collins,et al. Excitotoxic mechanisms of epileptic brain damage. , 1986, Advances in neurology.